Cardiovascular pathogenesis in hyperhomocysteinemia;Chinese Source

Asia Pacific Journal of Clinical Nutrition

Volumn 17, Issue 1, 2008, Pages 8-16

  Huang, Tao ^a,b   Yuan, Gaofeng ^a,b   Zhang, Zhiguo ^a,b   Zou, Zuquan ^a,b   Li, Duo ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b APCNS Centre of Nutrition and Food Safety   (China)

Author keywords

Homocysteine; Oxidizing stress; Proinflammatory; Smooth muscle cell; Teratogenic action

Indexed keywords

BLOOD; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; HUMAN; HYPERHOMOCYSTEINEMIA; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; THROMBOCYTE ACTIVATION;

BLOOD COAGULATION; CARDIOVASCULAR DISEASES; HUMANS; HYPERHOMOCYSTEINEMIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLATELET ACTIVATION; RISK FACTORS;

EID: 51649096936     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Vigneaud V du, Meyer CE. The racemization of amino acids in aqueous solution by acetic anhydride. J Biol Chem. 1932;295-308.
2. McCully KS. Vascular pathology of homocysteinemia implication for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111-l28.
3. Ueland PM, Refsum H, BrattstroÃm L. Plasma homocysteine and cardiovascular disease. In: RBJ Francis (ed). Atherosclerotic Cardiovascular Disease, Hemostasis and Endothelial Function. New York: Marcel Dekker. 1992; 183-236.
4. Kaul S, Zadeh AA, Shah PK. Homocysteine hypothesis for atherothrombotic cardiovascular disease, not validated. J Am Colle Cardiol. 2006;48:914-923.
5. Dinleyici EC, Kirel B, Alatas O, Muslumanoglu H, Kilic Z, Dogruel N. Plasma total homocysteine levels in children with type 1 diabetes: Relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors. J Tropical Pediatrics. 2006;52:260-266.
6. Moat SJ, Larig D, McDowell FW, Clarke ZL, Madhavan AK, Lewis MJ, Goodfellow J. Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem. 2004;15:64-79.
7. Faraci FM. Hyperhomocysteinaemia a million ways to lose control. Arterioscler Thromb Vasc Biol. 2003;23:371-373.
8. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations an expert opinion. Clin Chem. 2004;50:30-32.
9. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem. 1993;39: 1764-1779.
10. Fenton W, Rosenberg LE. Inherited disorders of cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D. The Metabolic and Molecular Basis of Inherited Disease. New York, NY: McGraw-Hill Publishing Co; 1995.p.3129-3150.
11. Rosenblatt DS. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. New York, NY: McGraw-Hill Publishing Co; 1995.p. 3111-3128.
12. Hamelet J, Demuth K, Paul JL, Delabar JM, Janel N. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice. J Hepato. 2007;46:151-159.
13. Katsushima F, Oliveriusova J, Sakamoto O, Ohura T, Kondo Y, Iinuma K, Kraus E, Stouracova R, Kraus JP. Expression study of mutant cystathionine β-synthase found in Japanese patients with homocysteinemia. Mol Genet Metab. 2006;87:323-328.
14. Pezzini A, Del Zotto E, Padovani A. Homocysteine and cerebral ischemia: pathogenic and therapeutical implications. Curr Med Chem. 2007;14:249-253.
15. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR Studies Collaboration Group, MTHFR 677C →T polymorphism and risk of coronary heart disease a meta-analysis. JAMA. 2002;288:2023-2031.
16. Wang XL, Duarte N, Cai H, Adachi T, Sim AS, Cranney G, Wilcken DL. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population. Atherosclerosis. 1999;146:133-140.
17. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270: 2693-2698.
18. 6 with bone mineral density in postmenopausal British women. Bone. 2007;40:730-736.
19. Wang H. Mechanisms in homocysteine-induced vascular disease. Drug Discovery Today. 2005;2:25-31.
20. Boers GH, Smals AG, Trijbels FJ, Fowler B, Bakkeren JA, Schoonderwaldt HC, et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 1985;313:709-715.
21. Mueller T, Furtmueller B, Aigelsdorfer J, Luft C, Poelz W, Haltmayer M. Total serum homocysteine-a predictor of extracranial carotid artery stenosis in male patients with symptomatic peripheral arterial disease. Vasc Med. 2001;6: 163-167.
22. Podda GM, Lussana F, Moroni G, Faioni EM, Lombardi R, Fontana G, Ponticelli C, Maioli C, Cattaneo M. Abnormalities of homocysteine and B vitamins in the nephritic syndrome. Thromb Res 2007; In Press.
23. Van der Molen EF, Verbruggen B, Novakova I, Eskes TK, Monnens LA, Blom HJ. Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. BJOG. 2000;107(6):785-791.
24. Galdieri LC, Arrieta SR, Silva CMC, Pedra CAC, Almeida VD. Homocysteine concentrations and molecular analysis in patients with congenital heart defects. Arch Med Res. 2007;38:212-218.
25. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry. 1998;13:235-239.
26. Masaki T, Anan F, Anai M, Higuchi K, Tsubone T. Hyperhomocysteinemia is associated with visceral adiposity in Japanese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2007; In Press.
27. Herrmann W, Herrmann M, Obeid R. Hyperhomocysteinaemia: a critical review of old and new aspects. Current Drug Metab. 2007;8:17-31.
28. Ygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230-236.
29. Asfar S, Safar HA. Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature. J Cardiovasc Surg (Torino). 2007; 48:601-605.
30. Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Arterioscler Thromb Vasc Biol. 1997;17:2074-2081.
31. 12 and folate. Am J Epidemiol. 1996;143:845-849.
32. Omara S, Ghorbelb IB, Fekic H, Souissi M. Hyperhomocysteinemia is associated with deep venous thrombosis of the lower extremities in Tunisian patients. Clin Biochem. 2007;40:41-45.
33. Oger E, Lacut K, Le Gal G, Couturaud F, Guenet D, Abalain JH, Roguedas AM, Mottier D. Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study. J Thromb Haemost. 2006;4:793-797.
34. Ernest S. Homocysteine levels in A/J and C57BL/6J mice: genetic, diet, gender, and parental effects. Physiological Genomics. 2005;21:404-410.
35. Oger E, Lacut K, Le Gal G, Couturaud F, Abalain JH, Mercier B, Mottier D. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: A hospital-based case-control study. Thromb Res. 2007;120(2):207-214.
36. Faeh D, Chiolero A, Paccaud F. Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about it? Swiss Med Wkly. 2006;136:745-756.
37. McGuigan AP, Sefton MV. The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials. 2007;28: 2547-2571.
38. Ramzy D, Rao V, Tumiati LC, Xu N, Sheshgiri R. Endothelin-1 accentuates the proatherosclerotic effects associated with C-reactive protein. J Thoracic Cardiovasc Surg. 2007;133:1137-1146.
39. Zhang HS, Cao EH, Qin JF. Homocysteine induces cell cycle G1 arrest in endothelial cells through the PI3K/Akt/FOXO signaling pathway. Pharmacology. 2005;74: 57-64.
40. Lee SJ, Kim KM, Namkoong S, Kim CK, Kang YC, Lee H, et al. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J Biol Chem. 2005;280:5781-5788.
41. Shastry S, Tyagi SC. Homocysteine induces metalloproteinase and shedding of beta-1 integrin in microvessel endothelial cells, J Cell Biochem. 2004;93:207-213.
42. Wang H, Jiang XH, Yang F, Chapman GB, Durante W, Sibinga ES, Schafer AI. Cyclin A transcriptional suppression is the major mechanism mediating homocysteineinduced endothelial cell growth inhibition. Blood. 2002;99: 939-945.
43. Wang H, Yoshizumi M, Lai K, Tsai JC, Perrella MA, Haber E, Lee ME. Inhibition of growth and p21 ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem. 1997;272:25380-25385.
44. Drunat S, Moatti N, Demuth K. Homocysteine decreases endothelin-1 expression by interfering with the AP-1 signaling pathway. Free Radic Biol Med. 2002;33:659-668.
45. Podder R, Sivamnanian N, Dibeno PM, Robinson K, Jacobsen DW. Homocysteine Induces Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Aortic Endothelial Cells. Circulation. 2001;l03:2717-2723.
46. Tasatargil A, Sadan G, Karasu E. Homocysteine-induced changes in vascular reactivity of guinea-pig pulmonary arteries: Role of the oxidative stress and poly (ADP-ribose) polymerase activation. Pulm Pharmacol Ther. 2007;20: 265-272.
47. Zhang BQ, Hu SJ, Qiu LH, Zhu JH, Xie XJ, Sun J, Zhu ZH, Xia Q, Bian K. Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine. Vascul Pharmacol. 2007;46: 278-285.
48. Meye C, Schumann J, Wagner A, Gross P. Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells. Atherosclerosis. 2007;190:256-263.
49. Perla-Kajan J, Twardowski T, Jakubowski H. Mechanisms of homocysteine toxicity in humans. Amino Acids. 2007; In Press
50. Castro R, Rivera I, Blom HJ, Jakobs C. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview. J Inherit Metab Dis. 2006;29:3-20.
51. Boot MJ, Steegers-Theunissen RPM, Poelmann RE, van Iperen L, Gittenberger-de Groot AC. Homocysteine induces endothelial cell detachment and vessel wall thickening during chick embryonic development. Circ Res. 2004; 94:542.
52. Li Zhang. Homocysteine stimulates nuclear factor βB activity and interleukin-6 expression in rat vascular smooth muscle cells. Cell Biol Int. 2006;30:592-597.
53. Van Akon BE, Jansen J, Deventer SJ, Reitsma PH. Elevated levels of homocysteine increase IL-6 production in monocytic cells. Blood Coagul Fibrinoiysis. 2000;11:159-164.
54. Rasmussen LM, PR Hansen, T Ledet. Homocystine and the production of collagens proliferation and apoptosis in human arterial smooth muscle cells. Acta Pathologica Microbiol Immunol Scandinavica. 2004;112:599-604.
55. Chen C, Halkos ME, Surowiec SM, Conklin BS, Lin PH, Lumsden AB. Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models. J Surg Res. 2000;88:26-33.
56. Cai BZ, Gong DM, Pan ZW, Liu Y, Qian H, Zhang Y, Jiao JD, Lu YJ, Yang BF. Large-conductance Ca2+-activated K+ currents blocked and impaired by homocysteine in human and rat mesenteric artery smooth muscle cells. Life Sci. 2007; In Press
57. Carmody BJ, Arora S, Avena R, Cosby K, Sidawy AN. Folic acid inhibits homocysteine-induced proliferation of human arterial smooth muscle cells. J Vasc Surg. 1999;30: 1121-1128.
58. Barter PJ, Rye KA. Homocysteine and cardiovascular disease: is HDL the link? Circ Res. 2006;99:565-566.
59. Ramakrishnan R, Sulochana S, Lakshmi KN, Selvi S, Angayarkanni R. Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys. 2006;43:275-283.
60. Zhang RF, Mild MJ. Hyperhomocysteinemia induced by feeding rats diets rich in methionine or deficient in folate promotes early. J Nutr. 2004;134:825-830.
61. Endo N, Nishiyama K, Okabe M, Matsumoto M, Kanouchi H, Oka T. Vitamin B6 suppresses apoptosis of NM-1 bovine endothelial cells induced by homocysteine and copper. Biochim Biophys Acta. 2007;1770:571-577.
62. Nakano E, Williamson MP, Williams NH, Powers HJ. Copper-mediated LDL oxidation by Hcy and related compounds depends largely on copper ligation. Biochim Biophys Acta. 2004;1688:33-42.
63. Exner M, Hermann M, Hofbauer R, Hartmann B, Kapiotis S, Gmeiner B. Hcy promotes the LDL oxidase activity of ceruloplasmin. FEBS Lett. 2002;531:402-406.
64. Konukoglu D, Serin O, Ercan M, Turhan MS. Plasma Hcy levels in obese and non-obese subjects with or without hypertension; its relationship with oxidative stress and copper. Clin Biochem. 2003;36:405-408.
65. Dai J, Li W, Chang L, Zhang ZM, Tang CS, Wang NP, Zhu Y, Wang X. Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis. Free Radic Bio Med. 2006;41:1566-1577.
66. Reiner AP, Kumar PN, Schwartz SM, Longstreth WT, Pearce RM, Rosendaal FR, Psaty BM, Siscovick DS. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke. 2000;31:1628-1633.
67. Guba SC, Fonseca V, Fink LM. Hyperhomocysteinemia and thrombosis. Semin Thromb Hemost. 1999;25:291-309.
68. Paolo P, Amato S, Minniti G, et al. von Willebr and factor multimer composition is modified following oral methionine load in women with thrombosis, but not in healthy women. Blood Coagul Fibrinolysis. 2005;16:267-273.
69. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest. 1996;98:24-29.
70. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb Vasc Biol. 1993;13: 1327-1333.
71. Hajjar KA. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest. 1993;91:2873-2879.
72. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest. 1991; 88:1906-1914.
73. 2 activity in isolated arterioles and platelets of rats with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 2000;20:l203-l208.
74. Durand P, Lussier-Cacan S, Blache D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophagederived tissue factor activity in rats. FASEB. 1997;11: 1157-1168.
75. Riba R, Nicolaou A, Troxler M, Vaniasinkam SH, Naseem KM. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis. 2004;75: 69-75.
76. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;9:308-3l8.
77. Undas A, Brozek J, Jankowski M, Siudak Z, Szczeklik A, Jakubowski H. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler Thromb Vasc Biol. 2006;26:1397-1404.
78. Rosenquist TH, Ratashak SA, Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA. 1996;93: 15227-15232.
79. Wenstrom KD, Joahnning G.L, Johnston KE, DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol. 2001; 184:806-817.
80. Tierney BJ, Ho T, Reedy MV, Brauer PR. Homocysteine inhibits cardiac neural crest cell formation and morphogenesis in vivo. Dev Dyn. 2004;1:63-73.
81. Bennett GD, Moser K, Chaudoin T, Rosenquist TH. The expression of the NR1-subunit of the NMDA receptor during mouse and early chicken development. Reprod Toxicol. 2006;22:536-541.
82. Limpach A. Dalton M, Miles R, Gadson P. Homocysteine inhibits retinoic acid synthesis: A mechanism for homocysteine-induced congenital defects. Exp Cell Res. 2000;260:166-174.
83. Zeng XK, Dai J, Remick DG, Wang X. Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res. 2003;93:311-320.
84. Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of m onocyte chemo attractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation. 2001;103:2717-2723.
85. Wang G, Dai J, Mao J, Zeng X, Yang X, Wang X. Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia. Atherosclerosis. 2005;179:395-402.
86. Sung FL, Siow YL, Wang GP, Lynn EG, Karmin O. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis. Biomed Life Sci. 2004; 216:121-128.
87. Zhang L, Jin M, Hu XS, Zhu JH. Effect of homocysteine on expression of interleukin-6 and NF-kappa B activity in cultured rat vascular smooth muscle cell. Cell Biol Int. 2006;30:592-597.
88. Silverman MD, Tumuluri RJ, Davis M, G Lopez, Rosenbaum JT, Lelkes PI. Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion arteriosclerosis. Arterioscler Thromb Vasc Biol. 2002;22:587-592.
89. Su TC, Jing JS, Wang JD, Torng PL, Chang SJ, Chen CF, Liau CS. Homocysteine, circulating vascular cell adhesion molecule and carotid atherosclerosis in postmenopausal vegetarian women and omnivores. Atherosclerosis. 2006; 184:356-362.
90. Postea O, Krotz F, Henger A, Keller C, Weiss N. Stereospecifie and redox sensitive increase in monocyte adhesion to endothelial cells by homocysteine. Arterioscler Thromb Vasc Biol. 2006;26:508-512.
91. Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells. Circulation. 2001;103:2717-2721.
92. Murakami T, Hino SI, Saito A. Endoplasmic reticulum stress response in dendrites of cultured primary neurons. Neuroscience. 2007;14:1-8.
93. Hamelet J, Demuth K, Paul JL. Hperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice. J Hepato. 2007;46:151-159.
94. Nonaka H, Tsujino T, Watari Y, Emoto N, Yokoyama M. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation. 2001; 104:1165-1170.
95. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 2000; 102:2479-2483.
96. Title LM, Cummings PM, Giddens K, Genest JJ, Nassar BM. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol. 2000;36:758-765.
97. Yap S, Naughten ER, Wilcken B, Wilcken DEL, Brenton DP, Lee PJ, Walter JH, Howard PM, Naughten ER. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy. Semin Thromb Hemost. 2000;26:335-340.
98. Heijer M den, Brouwer IA, Bos GMJ, Blom HJ, Put MJ van der, Spaans AP, et al. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vasc Biol. 1998;18:356-361.
99. Amy LY, Harvey LL. The use of betaine in the treatment of elevated homocysteine. Mol Genet Metab 2006; 88:201-207.
100. Ling H. High prevalence of hyperhomocysteinemia in chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status. The American Society for Nutrition. J Nutr. 2007;137:407-413.
101. 12, and serum total homocysteine levels in confirmed Alzheimer Disease. Arch Neurol. 1998;55:1449-1455.
102. Bergen C, Compher C. Total homocysteine concentration and associated cardiovascular and renal implications in Adults. J Cardiovasc Nurs. 2006;21:40-46.
103. Griend R, Biesma DH, Haas FJ, Faber JAJ, Duran M, Meuwissen OJATH, Banga JD. The effect of different treatment regimens in reducing fasting and postmethionineload homocysteine concentrations. J Intern Med. 2000;248: 223-229.
104. Symons JD, Rutledge JC, Simonsen U, Pattathu RA. Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate. Am J Physiol Heart Circ Physiol. 2006;290:H181-H191.
105. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Held C, Genest J. The heart outcomes prevention evaluation (HOPE) 2 investigators. Homocysteine lowering with folic acid and B Vitamins in vascular disease. N Engl J Med. 2006;355:746-750.
106. Donnell JO, Perry DJ. Pharmacotherapy of hyperhomocysteinemia in patients with thrombophilia. Expert Opin Pharmacother. 2002;3:1591-1598.
107. Lamers Y, Prinz-Langenohl R, Moser R, Pietrzik K. Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. Am J Clin Nutr. 2004;79:473-478.
108. 12 and methionine synthesis: A critical review. Is nature's most beautiful cofactor misunderstood? Biofactors. 2006;26:45-57.
109. Kim JH, Cho SY, Lee JH, Jeong SM, Yoon IS, Lee BH, et al. Neuro-protective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus. Brain Res. 2007;1136:190-199.
110. Li D, Yu XM, Xie HB, Zhang YH, Wang Q, Zhou XQ, Yu P, Wang LJ. Platelet phospholipids n-3 PUFA negatively associated with plasma homocysteine in middle aged and geriatric hyperlipaemia patients. Prostag Leukotr Essent Fatty Acids. 2007. In Press.
111. Li D, Mann NJ, Sinclair AJ. A significant inverse relationship between concentrations of plasma homocysteine and phospholipids docosahexaenoic acid in healthy male subjects. Lipids. 2006;41:85-89.
112. Li D. Omega-3 fatty acid and non-communicable diseases. Chin Med J. 2003;116:453-458.